Filing Flows › Comparisons › CAI vs VCYT
Caris Life Sciences vs Veracyte: CAI and VCYT compared
Caris Life Sciences is the larger company: $275M of revenue in its latest quarter (Q3 2026) against $152M for Veracyte (Q3 2026). Caris Life Sciences is growing faster (+27% against +15% a year earlier). Veracyte is more profitable, with an operating margin of 10.9% against 7.0%.
Where the money goes: CAI and VCYT
Caris Life Sciences (CAI) · Q3 2026
Caris Life Sciences, Q3 2026: revenue $275M (+27% year over year), operating margin 7.0%, net earnings $15.2M, operating cash flow −$22.2M. The chart follows the revenue to costs, profit and cash.
Veracyte (VCYT) · Q3 2026
Veracyte, Q3 2026: revenue $152M (+15% year over year), operating margin 10.9%, net earnings $31.5M, operating cash flow $40.3M. The chart follows the revenue to costs, profit and cash.
| Caris Life Sciences (CAI) | Veracyte (VCYT) | |
|---|---|---|
| Latest quarter | Q3 2026 | Q3 2026 |
| Revenue | $275M | $152M |
| Revenue growth, Y/Y | +27% | +15% |
| Gross margin | — | 70.6% |
| Operating margin | 7.0% | 10.9% |
| Net earnings | $15.2M | $31.5M |
| Net margin | 5.5% | 20.8% |
| Operating cash flow | −$22.2M | $40.3M |
| Free cash flow | — | $37.9M |
| Market value | — | $3.7B |
| P/E | — | 32.4× |
| Analysts’ mean target | — | $57.40 |
Where the revenue comes from
Caris Life Sciences
- Molecular Profiling Services: $263M (95%)
- Pharma Research and Development Services: $12.7M (5%)
Veracyte
- Testing revenue: $146M (96%)
- Product revenue: $4.6M (3%)
- Biopharmaceutical and other revenue: $709K (0%)
Questions
Which is bigger, Caris Life Sciences or Veracyte?
Caris Life Sciences is the larger company: $275M of revenue in its latest quarter (Q3 2026) against $152M for Veracyte (Q3 2026).
Is Caris Life Sciences or Veracyte growing faster?
Caris Life Sciences is growing faster (+27% against +15% a year earlier).
Which is more profitable, Caris Life Sciences or Veracyte?
Veracyte is more profitable, with an operating margin of 10.9% against 7.0%.
More: Caris Life Sciences earnings · how Caris Life Sciences makes money · Veracyte earnings · how Veracyte makes money
From the companies' latest 10-Q, 10-K or earnings release (10-Q filed Nov 4, 2026; 10-Q filed Nov 5, 2026). Fiscal quarters can end on different dates. Not investment advice.